About Dzyris Pharmaceuticals Private Limited
Data last updated:
Dzyris Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC360043. Its GSTIN is 27AAICD4856G1ZF (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sannjay Sahabal Yadav and Jeetendra Yadav.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Gala No 7/D Ghanshyam Dube Chawl Near Bmc School S V Road Dahisar East., Mumbai, Maharashtra, India – 400068.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.16 Lakh. For the same year it recorded a net loss of ₹10.84 Lakh and EBITDA of -₹10.79 Lakh.
For more details, the company can be reached via its website dzyris.in.
Company details
Contact details
Dzyris Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is dzyris.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGala No 7/D Ghanshyam Dube Chawl Near Bmc School S V Road Dahisar East., Mumbai, Maharashtra, India – 400068
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dzyris Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dzyris Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Dzyris Pharmaceuticals Private Limited, buy the company report.
Financials of Dzyris Pharmaceuticals Private Limited
FY 2023 filings availableDzyris Pharmaceuticals Private Limited reported revenue of ₹1.16 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹1.16 Lakh | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹10.79 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹10.84 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Dzyris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dzyris Pharmaceuticals Private Limited
Dzyris Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sannjay Sahabal Yadav Also directs: Urbanhome Advisors LLP | Director | 07 May 2021 | 5 Years 6 Months | Current |
| Jeetendra Yadav | Director | 07 May 2021 | 5 Years 6 Months | Current |
| Rakesh Kumar Yadav | Director | 07 May 2021 | 5 Years 6 Months | Current |
| Nitin Bhimashankar Gopale | Director | 10 Feb 2025 | 1 Years 8 Months | Current |
Auditor
Dzyris Pharmaceuticals Private Limited is audited by K H DOSHI & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K H DOSHI & ASSOCIATES LLP | FY 2023 | 100270W |
Shareholding
The shareholding of Dzyris Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Dzyris Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dzyris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dzyris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dzyris Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Dzyris Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICD4856G1ZF | Maharashtra | Active | 14 May 2021 |
To see the full GST registrations and return filing status of Dzyris Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dzyris Pharmaceuticals Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Nitin Bhimashankar Gopale was appointed as Director on 10 Feb 2025.
Frequently asked questions
Dzyris Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 May 2021 (5+ years old) and is registered under CIN U51909MH2021PTC360043.
Dzyris Pharmaceuticals has 4 current directors:
- Sannjay Sahabal Yadav - Director
- Jeetendra Yadav - Director
- Rakesh Kumar Yadav - Director
- Nitin Bhimashankar Gopale - Director
The latest financial statements of Dzyris Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Dzyris Pharmaceuticals is 27AAICD4856G1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dzyris Pharmaceuticals is U51909MH2021PTC360043. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dzyris Pharmaceuticals was incorporated on 07 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Nitin Bhimashankar Gopale was appointed as Director on 10 Feb 2025. Jeetendra Yadav was appointed as Director on 07 May 2021. Rakesh Kumar Yadav was appointed as Director on 07 May 2021. Dzyris Pharmaceuticals has 4 board changes on record in total.
Dzyris Pharmaceuticals can be reached through the website dzyris.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Dzyris Pharmaceuticals is at Gala No 7D Ghanshyam Dube Chawl Near Bmc School S V Road Dahisar East., Mumbai, Maharashtra, India – 400068.
Dzyris Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
